R. Smits, et.al., Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity., Genes, chromosomes & cancer, 2000, 29

http://rdf.ncbi.nlm.nih.gov/pubmed/10992298

R. Smits, et.al., Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity., Genes, chromosomes & cancer, 2000, 29

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD01508
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD01508

allele

http://purl.org/net/cito/citesAsAuthority

• Msh2<tm1Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2151801

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased tumor incidence_Apc<tm1Rak>/Apc<+>,Msh2<tm1Rak>/Msh2<tm1Rak>
  http://metadb.riken.jp/0002020I129P2OlaHsdApctm1RakApcMsh2tm1RakMsh2tm1RakMsh2tm1RakApctm1RakApc
• increased lymphoma incidence_Msh2<tm1Rak>/Msh2<tm1Rak>
  http://metadb.riken.jp/0012431I129P2OlaHsdMsh2tm1RakMsh2tm1RakMsh2tm1Rak
• colon polyps_Msh2<tm1Rak>/Msh2<+>
  http://metadb.riken.jp/0003269I129P2OlaHsdMsh2tm1RakMsh2Msh2tm1RakMsh2
• increased lymphoma incidence_Msh2<tm1Rak>/Msh2<+>
  http://metadb.riken.jp/0012431I129P2OlaHsdMsh2tm1RakMsh2Msh2tm1RakMsh2
• increased liver adenoma incidence_Msh2<tm1Rak>/Msh2<+>
  http://metadb.riken.jp/0003324I129P2OlaHsdMsh2tm1RakMsh2Msh2tm1RakMsh2
• premature death_Msh2<tm1Rak>/Msh2<tm1Rak>
  http://metadb.riken.jp/0002083I129P2OlaHsdMsh2tm1RakMsh2tm1RakMsh2tm1Rak
• increased tumor incidence_Msh2<tm1Rak>/Msh2<+>
  http://metadb.riken.jp/0002020I129P2OlaHsdMsh2tm1RakMsh2Msh2tm1RakMsh2
• increased gastrointestinal tumor incidence_Msh2<tm1Rak>/Msh2<tm1Rak>
  http://metadb.riken.jp/0010279I129P2OlaHsdMsh2tm1RakMsh2tm1RakMsh2tm1Rak
• premature death_Apc<tm1Rak>/Apc<+>,Msh2<tm1Rak>/Msh2<tm1Rak>
  http://metadb.riken.jp/0002083I129P2OlaHsdApctm1RakApcMsh2tm1RakMsh2tm1RakMsh2tm1RakApctm1RakApc